Medical Device | May 27, 2026
Align Tech to open $200M manufacturing facility in Hyderabad aiming 300+ jobs
The new facility marks Align’s first manufacturing presence in India and its fourth globally
The new facility marks Align’s first manufacturing presence in India and its fourth globally
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
We are contributing to the Indian pharmaceutical and laboratory sectors through advanced analytical instrumentation, automated liquid handling, and molecular biology solutions. Our technologies empower research and Quality Control (QC) by ensuring regulatory compliance and streamlined workflows…
Our Global Capability Center (GCC) in Bengaluru drives our major software development initiatives. Complementing this, our Bengaluru facility manufactures antibodies for research and diagnostics. Through these integrated technology and biotech operations, we are proud to contribute to India’s growth story in the life sciences sector.
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Subscribe To Our Newsletter & Stay Updated
